{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:24:44Z","timestamp":1790112284271,"version":"4.0.1"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,20]],"date-time":"2017-12-20T00:00:00Z","timestamp":1513728000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["16-14-00224"],"award-info":[{"award-number":["16-14-00224"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Talanta"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.talanta.2017.12.055","type":"journal-article","created":{"date-parts":[[2017,12,18]],"date-time":"2017-12-18T21:32:58Z","timestamp":1513632778000},"page":"282-291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"special_numbering":"C","title":["Thrombodynamics, a new global coagulation test: Measurement of heparin efficiency"],"prefix":"10.1016","volume":"180","author":[{"given":"Elena\u00a0I.","family":"Sinauridze","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana\u00a0A.","family":"Vuimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan D.","family":"Tarandovskiy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruzanna A.","family":"Ovsepyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stepan S.","family":"Surov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia G.","family":"Korotina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilya I.","family":"Serebriyskiy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxim M.","family":"Lutsenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander L.","family":"Sokolov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fazoil I.","family":"Ataullakhanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.talanta.2017.12.055_bib1","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/anae.12919","article-title":"Laboratory monitoring of hemostasis","volume":"70","author":"Fowler","year":"2015","journal-title":"Anaestesia"},{"key":"10.1016\/j.talanta.2017.12.055_bib2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.bpa.2009.09.009","article-title":"Perioperative coagulation monitoring","volume":"24","author":"Kozek-Langenecker","year":"2010","journal-title":"Best Pract. Res. Clin. Anaesthesiol."},{"key":"10.1016\/j.talanta.2017.12.055_bib3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000350469","article-title":"State of the art in platelet function testing","volume":"40","author":"Kehrel","year":"2013","journal-title":"Transfus. Med.\u00a0Hemother."},{"key":"10.1016\/j.talanta.2017.12.055_bib4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12959-014-0032-y","article-title":"Global\/integral assays in hemostasis diagnostics: promises, successes, problems and prospects","volume":"13","author":"Panteleev","year":"2015","journal-title":"Thromb. J."},{"key":"10.1016\/j.talanta.2017.12.055_bib5","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12959-015-0038-0","article-title":"Global assays of hemostasis in the diagnostics of hypercoagulation and evaluation of thrombosis risk","volume":"13","author":"Lipets","year":"2015","journal-title":"Thromb. J."},{"key":"10.1016\/j.talanta.2017.12.055_bib6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12959-015-0036-2","article-title":"Assays of different aspects of haemostasis \u2013 what do they measure?","volume":"13","author":"Tynng\u00e5rd","year":"2015","journal-title":"Thromb. J."},{"key":"10.1016\/j.talanta.2017.12.055_bib7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/bjh.13930","article-title":"The place of viscoelastic testing in clinical practice","volume":"173","author":"Hans","year":"2016","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.talanta.2017.12.055_bib8","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1309\/Q4AE-BMCW-CQ7J-NUVT","article-title":"Effects of unfractionated heparin, low-molecular-weight heparin, and heparinoid on thromboelastographic assay of blood coagulation","volume":"113","author":"Zmuda","year":"2000","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.talanta.2017.12.055_bib9","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1365-2516.2010.02451.x","article-title":"Standardization of thromboelastography: a report from the TEG-ROTEM working group","volume":"17","author":"Chitlur","year":"2011","journal-title":"Haemophilia"},{"key":"10.1016\/j.talanta.2017.12.055_bib10","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000073575","article-title":"The calibrated automated thrombogram (CAT): a universal routine test for hyper- and hypocoagulability","volume":"32","author":"Hemker","year":"2002","journal-title":"Pathophysiol. Haemost. Thromb."},{"key":"10.1016\/j.talanta.2017.12.055_bib11","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000071636","article-title":"Calibrated automated thrombin generation measurement in clotting plasma","volume":"33","author":"Hemker","year":"2003","journal-title":"Pathophysiol. Haemost. Thromb."},{"key":"10.1016\/j.talanta.2017.12.055_bib12","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1111\/j.1538-7836.2004.00798.x","article-title":"Thrombin generation for the control of heparin treatment, comparison with the activated partial thromboplastin time","volume":"2","author":"Al Dieri","year":"2004","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.talanta.2017.12.055_bib13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.thromres.2010.07.024","article-title":"Inter-individual variability of effect of 7 low molecular weight antithrombin-dependent anticoagulants studied in vitro with calibrated automated thrombography","volume":"127","author":"Hacquard","year":"2011","journal-title":"Thromb. Res."},{"key":"10.1016\/j.talanta.2017.12.055_bib14","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3324\/haematol.2012.073601","article-title":"Large inter-individual variation of the pharmacodynamic effect of anticoagulant drugs on thrombin generation","volume":"98","author":"Bloemen","year":"2013","journal-title":"Haematologi\u0441a"},{"key":"10.1016\/j.talanta.2017.12.055_bib15","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1309\/AJCPS6OW6DYNOGNH","article-title":"Activated partial thromboplastin time and anti-Xa measurements in heparin monitoring: biochemical basis for discordance","volume":"139","author":"Takemoto","year":"2013","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.talanta.2017.12.055_bib16","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1160\/TH14-05-0452","article-title":"Thrombin generation and low-molecular-weight heparin prophylaxis in pregnant women with thrombophilia","volume":"113","author":"Selmeczi","year":"2015","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.talanta.2017.12.055_bib17","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/bjh.13193","article-title":"Thrombin generation assay identifies individual variability in responses to low molecular weight heparin in pregnancy: implications for anticoagulant monitoring","volume":"168","author":"Chowdary","year":"2015","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.talanta.2017.12.055_bib18","doi-asserted-by":"crossref","unstructured":"D.A. Garcia, T.P. Baglin, J.I. Weitz, M.M. Samama, American College of Chest Physicians, Parenteral Anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, Chest, 141, 2012, pp. e24S\u201343S.\u00a0\u3008https:\/\/dx.doi.org\/10.1378\/chest.11-2291\u3009.","DOI":"10.1378\/chest.11-2291"},{"key":"10.1016\/j.talanta.2017.12.055_bib19","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1365-2362.1986.tb02174.x","article-title":"Heparin half-life and sensitivity in normal subjects and in patients affected by deep vein thrombosis","volume":"16","author":"Benchekroun","year":"1986","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.talanta.2017.12.055_bib20","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1213\/ANE.0b013e31827e4e62","article-title":"Heparin sensitivity and resistance: management during cardiopulmonary bypass","volume":"116","author":"Finley","year":"2013","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.talanta.2017.12.055_bib21","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1055\/s-0038-1646593","article-title":"Unfractionated heparin and CY 216: pharmacokinetics and bioavailabilities of the antifactor Xa and IIa effects after intravenous and subcutaneous injection in the rabbit","volume":"61","author":"Briant L","year":"1989","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.talanta.2017.12.055_bib22","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1161\/01.ATV.17.8.1568","article-title":"Induction of the acute-phase reaction increases heparin-binding proteins in plasma","volume":"17","author":"Young","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.talanta.2017.12.055_bib23","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0002-9149(93)91139-9","article-title":"Comparison of efficacy of low molecular weight heparin (parnaparin) with that of unfractionated heparin in the presence of activated platelets in healthy subjects","volume":"72","author":"Melandri","year":"1993","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.talanta.2017.12.055_bib24","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/0049-3848(78)90271-2","article-title":"Binding of heparin on the surface of cultured human endothelial cells","volume":"12","author":"Glimelius","year":"1978","journal-title":"Thromb. Res."},{"key":"10.1016\/j.talanta.2017.12.055_bib25","unstructured":"C. Legnani, L. Preda, G. Palareti, B. Lunghi, E. Rossi, S. Coccheri, Reduced inhibition of activated prothrombin by heparin and venous thromboembolism: heparin resistence revisited, Haematologica, 87, 2002, pp. 182\u2013188. \u3008http:\/\/www.haematologica.org\/content\/haematol\/87\/2\/182.full.pdf\u3009 (Accessed 15 September 2017)."},{"key":"10.1016\/j.talanta.2017.12.055_bib26","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1182\/blood.V60.6.1251.1251","article-title":"Kinetics of intravenously administered heparin in normal humans","volume":"60","author":"De Swart","year":"1982","journal-title":"Blood"},{"key":"10.1016\/j.talanta.2017.12.055_bib27","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1055\/s-0037-1612960","volume":"87","author":"Greaves","year":"2002","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.talanta.2017.12.055_bib28","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1023\/A:1021298103264","article-title":"Activated clotting time systems vary in precision and bias and are not interchangeable when following heparin management protocols during cardiopulmonary bypass","volume":"17","author":"Welsby","year":"2002","journal-title":"J. Clin. Monit. Comput."},{"key":"10.1016\/j.talanta.2017.12.055_bib29","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1055\/s-0038-1649948","article-title":"Response of the activated partial thromboplastin time (APTT) to heparin is influenced by coagulometers","volume":"74","author":"van den Besselaar","year":"1995","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.talanta.2017.12.055_bib30","unstructured":"Clexane\u00ae and Clexane\u00ae Forte, \u3008http:\/\/www.medsafe.govt.nz\/profs\/datasheet\/c\/clexaneinj.pdf\u3009 (Accessed 15 September 2017)."},{"key":"10.1016\/j.talanta.2017.12.055_bib31","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/MBC.0b013e328355c9cb","article-title":"Anticoagulant therapy: basic principles, classic approaches and recent developments","volume":"23","author":"Sinauridze","year":"2012","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.talanta.2017.12.055_bib32","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.2165\/00003088-200342120-00003","article-title":"Pharmacodynamic and pharmacokinetic properties of enoxaparin: implications for clinical practice","volume":"42","author":"Fareed","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.talanta.2017.12.055_bib33","unstructured":"Enoxaparin, \u3008http:\/\/cardiolog.org\/lekarstva\/88-anticoaguljanty-nmg\/199-enoxaparin.html\u3009 (in Russian) (Accessed 15 September 2017)."},{"key":"10.1016\/j.talanta.2017.12.055_bib34","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1538-7933.2004.00648.x","article-title":"Is laboratory monitoring of low-molecular-weight heparin therapy necessary? No","volume":"2","author":"Bounameaux","year":"2004","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.talanta.2017.12.055_bib35","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1538-7836.2005.01672.x","article-title":"Fixed dosage of low-molecular-weight heparins causes large individual variation in coagulability, only partly corrected to body weight","volume":"4","author":"Al Dieri","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.talanta.2017.12.055_bib36","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2165\/00002018-200528040-00005","article-title":"Safe profile of different low-molecular-weight heparins used at therapeutic dose","volume":"28","author":"Gouin-Thibault","year":"2005","journal-title":"Drug Saf."},{"key":"10.1016\/j.talanta.2017.12.055_bib37","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1538-7933.2004.00647.x","article-title":"Is laboratory monitoring of low-molecular-weight heparin therapy neccessary? Yes","volume":"2","author":"Harenberg","year":"2004","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.talanta.2017.12.055_bib38","first-page":"47","article-title":"Laboratory monitoring of heparin therapy: partial thromboplastin time or anti-Xa assay?","volume":"40","author":"Lehman","year":"2009","journal-title":"LabMedicine"},{"key":"10.1016\/j.talanta.2017.12.055_bib39","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1177\/1060028015578451","article-title":"Heparin-calibrated chromogenic anti-Xa activity measurements in patients receiving rivaroxaban: can this test be used to quantify drug level?","volume":"49","author":"Gosselin","year":"2015","journal-title":"Ann. Pharmacother."},{"issue":"Suppl. 1","key":"10.1016\/j.talanta.2017.12.055_bib40","first-page":"S89","article-title":"Factor Xa inhibition: correlation between the plasma levels of anti-Xa activity and occurrence of thrombosis and haemorrhage","volume":"23","author":"Leizorovicz","year":"1993","journal-title":"Haemostasis"},{"key":"10.1016\/j.talanta.2017.12.055_bib41","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1134\/S0006297910060088","article-title":"Thromboplastin immobilized on polystyrene surface exhibits kinetic characteristics close to those for the native protein and activates in vitro blood coagulation similarly to thromboplastin on fibroblasts","volume":"75","author":"Fadeeva","year":"2010","journal-title":"Biochemistry (Mosc.)"},{"key":"10.1016\/j.talanta.2017.12.055_bib42","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1365-2141.2005.05953.x","article-title":"British Committee for standards in haematology, guidelines on the use and monitoring of heparin","volume":"133","author":"Baglin","year":"2006","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.talanta.2017.12.055_bib43","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1046\/j.1365-2125.2002.t01-1-01705.x","article-title":"Quantification of heparin-induced TFPI release: a maximum release at low heparin dose","volume":"54","author":"Kemme","year":"2002","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.talanta.2017.12.055_bib44","doi-asserted-by":"crossref","first-page":"e55688","DOI":"10.1371\/journal.pone.0055688","article-title":"Antiplatelet agents can promote two-peaked thrombin generation in platelet-rich plasma: mechanism and possible applications","volume":"8","author":"Tarandovskiy","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.talanta.2017.12.055_bib45","doi-asserted-by":"crossref","first-page":"29242","DOI":"10.1038\/srep29242","article-title":"The modification of the thrombin generation test for the clinical assessment of dabigatran etexilate efficiency","volume":"6","author":"Gribkova","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.talanta.2017.12.055_bib46","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/MBC.0b013e328352e90e","article-title":"Predicting prothrombotic tendencies in sepsis using spatial clot growth dynamics","volume":"23","author":"Soshitova","year":"2012","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.talanta.2017.12.055_bib47","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1111\/j.1538-7836.2011.04412.x","article-title":"Improvement of spatial fibrin formation by the anti-TFPI aptamer BAX499: changing clot size by targeting extrinsic pathway initiation","volume":"9","author":"Parunov","year":"2011","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.talanta.2017.12.055_bib48","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.thromres.2013.12.014","article-title":"Effect of pre-analytical conditions on the thrombodynamics assay","volume":"133","author":"Dashkevich","year":"2014","journal-title":"Thromb. Res."},{"key":"10.1016\/j.talanta.2017.12.055_bib49","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.thromres.2013.10.036","article-title":"Drug-drug interaction of the anti-TFPI aptamer BAX499 and factor VIII: studies of spatial dynamics of fibrin clot formation in hemophilia A","volume":"133","author":"Parunov","year":"2014","journal-title":"Thromb. Res."},{"key":"10.1016\/j.talanta.2017.12.055_bib50","series-title":"An Introduction to Error Analysis. The Study of Uncertainties in Physical Measurements (Chapter 3: Propagation of Uncertainties)","first-page":"45","author":"Taylor","year":"1997"},{"key":"10.1016\/j.talanta.2017.12.055_bib51","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4103\/0253-7176.116232","article-title":"How to calculate sample size for different study designs in medical research?","volume":"35","author":"Charan","year":"2013","journal-title":"Indian J. Psychol. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.talanta.2017.12.055_bib52","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/ijlh.12658","article-title":"The danger of relying on the APTT and PT in patients on DOAC therapy, a potential patient safety issue","volume":"39","author":"Adcock","year":"2017","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.talanta.2017.12.055_bib53","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11239-015-1315-2","article-title":"Guidance for the practical management of the heparin anticoagulants in the treatment of venous thromboembolism","volume":"41","author":"Smythe","year":"2016","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.talanta.2017.12.055_bib54","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1001\/jama.296.8.935","article-title":"Fixed-dose heparin (FIDO) investigators, comparison of fixed-dose weight-adjusted unfractionated heparin and low-molecular-weight heparin for acute treatment of venous thromboembolism","volume":"296","author":"Kearon","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.talanta.2017.12.055_bib55","first-page":"36","article-title":"Criteria for efficacy of anticoagulant therapy in patients with thromboses of deep veins of lower limbs","volume":"21","author":"Krylov","year":"2015","journal-title":"Angiol. Sosud. Khir."},{"key":"10.1016\/j.talanta.2017.12.055_bib56","first-page":"33","article-title":"Coagulological aspects of treatment of complications of prolonged therapy with warfarin","volume":"22","author":"Krylov","year":"2016","journal-title":"Angiol. Sosud. Khir."}],"container-title":["Talanta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039914017312572?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039914017312572?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T09:26:09Z","timestamp":1603531569000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039914017312572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":56,"alternative-id":["S0039914017312572"],"URL":"https:\/\/doi.org\/10.1016\/j.talanta.2017.12.055","relation":{},"ISSN":["0039-9140"],"issn-type":[{"value":"0039-9140","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thrombodynamics, a new global coagulation test: Measurement of heparin efficiency","name":"articletitle","label":"Article Title"},{"value":"Talanta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.talanta.2017.12.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}